Patent ID: 7235675

Claim:
A ligand-inhibitor conjugate with the structure wherein n=1 and X is selected from the group consisting of —O—CONH—(CH 2 ) 2 -NH-thyroxine, —O—CONH—(CH 2 ) 2 —NHC(═C)—(CH 2 ) 4 -theophylline, —NH—CO—(CH 2 ) 3 -phenytoin, —O—CO[NH-gentamicin], —NH—CO-Ph-CO[NH-gentamicin] wherein Ph is phenyl, 5′-[[[(digoxin(1,4-oxazepin))-4-yl]-phenyl-4-carbonyl]amino]-, 5′-[[[(digitoxin(1,4-oxazepin))-4-yl]-phenyl-4-carbonyl]amino]-, and